Evidence map›Paper›PMID 42876982›Full record

ReviewFrontiers in pharmacology2026

Teaching the true cost of medicines: white paper for a green and sustainable pharmacology curriculum.

Ramamoorthy Rajkumar, Gavin S Dawe

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ramamoorthy RajkumarDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Gavin S DaweDepartment of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The drug lifecycle imposes a growing environmental burden, evident in pharmaceutical pollution, escalating consumption of finite resources (energy, water, and raw materials) and a substantial carbon footprint. Meeting these challenges requires more than technological fixes; it demands a workforce trained to recognise, evaluate, and reduce the environmental impacts of medicines while safeguarding patient outcomes. However, recent scoping and systematic reviews consistently note a gap in health professions education: few curricula provide structured, evidence-informed approaches for integrating environmental sustainability and planetary health into pharmacology and related training. The discipline of pharmacology is uniquely suited for integrating green and sustainability principles because it sits at the decision-point where molecular mechanisms become real-world medicine use and environmental impact. This paper presents a white paper proposing a Green and Sustainable Pharmacology Curriculum and an actionable strategy for embedding sustainability principles within core pharmacology teaching. Targeted at biomedical scientists, pharmacists, and prescribers, the curriculum is designed to strengthen decision-making across the medicine lifecycle, including greener selection, rational use, and responsible disposal. We outline a curriculum development framework that applies Understanding by Design and outcome-based evaluation through four streamlined steps: (1) needs analysis, (2) curation of priority content topics, (3) constructive alignment of learning activities with intended competencies, and (4) assessment aligned to learning outcomes. By offering an adaptable blueprint for local implementation, this white paper aims to accelerate adoption by pharmacology departments worldwide. Ultimately, the curriculum seeks to shift learners from concerned global citizens to empowered pharmacologists with personal agency implement workplace changes that mitigate environmental harms and to serve as thought leaders advancing sustainable healthcare.

Indexed as

curriculumdrug lifecyclegreenpharmacologysustainable

Identifiers

PMID42876982
PMCPMC13662423

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.